Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Jiayou Pharmaceutical Group is a comprehensive pharmaceutical enterprise headquartered in Nanjing, China, specializing in the research, development, production, and sale of chemical drugs and traditional Chinese medicines. Founded in 2003, the company has established a strong market presence in therapeutic areas such as gastroenterology, cardiovascular diseases, and anti-infectives. Its product portfolio features several widely used generic injectables, including proton pump inhibitors like omeprazole and pantoprazole. Jiayou operates multiple GMP-certified manufacturing facilities and maintains a dedicated R&D center focused on formulation innovation and consistency evaluation of generic drugs. The group continues to expand its footprint within the Chinese healthcare market through a robust distribution network and strategic industrial investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Jiayou Pharmaceutical.